Tag: Thromboembolism

Results of FRAIL-AF trial suggest increased bleeding risk with DOACs

Presented By
Dr Linda Joosten, University Medical Center Utrecht, the Netherlands
Trial
FRAIL-AF
Conference
ESC 2023

30 October 2023 16:04

New VOYAGER PAD data: Should patients with both PAD and CKD get rivaroxaban?

Presented By
Dr Mark Svet, University of Colorado, USA
Trial
VOYAGER-PAD
Conference
ACC 2022
Type
Peer-reviewed article

15 June 2022 15:24

Head-to-head: post-TAVR edoxaban not better than DAPT

Presented By
Prof. Duk-Woo Park, Asan Medical Center, Korea
Trial
Phase 4, ADAPT-TAVR
Conference
ACC 2022
Type
Peer-reviewed article

15 June 2022 14:09

POPular TAVI: Aspirin-only antiplatelet strategy?

Presented By
Dr Jorn Brouwer, St Antonius Hospital, the Netherlands
Trial
POPular TAVI trial
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 13:28

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By
Prof. Yutao Guo , Chinese PLA General Hospital, China
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 12:27

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By
Dr Kira MacDougall, Staten Island University Hospital, USA
Trial
PAUSE
Conference
ISTH 2020
Type
Peer-reviewed article

8 September 2020 16:27

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By
Dr G.R. Hong, Yonsei University College of Medicine, South Korea
Trial
ENAVLE
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:15
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com